Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: a systematic review and meta-analysis
Objective To study the correlation between gastrointestinal (GI) symptoms and disease severity in patients with COVID-19.Design We searched six databases including three Chinese and three English databases for all the published articles on COVID-19. Studies were screened according to inclusion and e...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | BMJ Open Gastroenterology |
Online Access: | https://bmjopengastro.bmj.com/content/7/1/e000437.full |
id |
doaj-3317f75b21fc4f01be41ade638832514 |
---|---|
record_format |
Article |
spelling |
doaj-3317f75b21fc4f01be41ade6388325142021-01-22T06:30:20ZengBMJ Publishing GroupBMJ Open Gastroenterology2054-47742020-11-017110.1136/bmjgast-2020-000437Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: a systematic review and meta-analysisTao Yang0Ping Yao1Min Cui2Gastroenterology, Xinjiang Medical University Affiliated First Hospital, Urumqi, Xinjiang, ChinaGastroenterology, Xinjiang Medical University Affiliated First Hospital, Urumqi, Xinjiang, ChinaGastroenterology, Xinjiang Medical University Affiliated First Hospital, Urumqi, Xinjiang, ChinaObjective To study the correlation between gastrointestinal (GI) symptoms and disease severity in patients with COVID-19.Design We searched six databases including three Chinese and three English databases for all the published articles on COVID-19. Studies were screened according to inclusion and exclusion criteria. The relevant data were extracted and all the statistical analyses were performed using Revman5.3.Result In a meta-analysis of 9 studies, comprising 3022 patients, 479 patients (13.7%, 95% CI 0.125 to 0.149) had severe disease and 624 patients (14.7%, 95% CI 0.136 to 0.159) had GI symptoms. Of 624 patients with GI symptoms, 118 patients had severe disease (20.5%, 95% CI 0.133 to 0.276) and of 2397 cases without GI symptoms, 361 patients had severe disease (18.2%, 95% CI 0.129 to 0.235). Comparing disease severity of patients with and without GI symptoms, the results indicated: I²=62%, OR=1.21, 95% CI 0.94 to 1.56, p=0.13; there was no statistically significant difference between the two groups. The funnel plot was symmetrical with no publication bias.Conclusion Current results are not sufficient to demonstrate a significant correlation between GI symptoms and disease severity in patients with COVID-19.https://bmjopengastro.bmj.com/content/7/1/e000437.full |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tao Yang Ping Yao Min Cui |
spellingShingle |
Tao Yang Ping Yao Min Cui Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: a systematic review and meta-analysis BMJ Open Gastroenterology |
author_facet |
Tao Yang Ping Yao Min Cui |
author_sort |
Tao Yang |
title |
Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: a systematic review and meta-analysis |
title_short |
Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: a systematic review and meta-analysis |
title_full |
Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: a systematic review and meta-analysis |
title_fullStr |
Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: a systematic review and meta-analysis |
title_full_unstemmed |
Correlation between gastrointestinal symptoms and disease severity in patients with COVID-19: a systematic review and meta-analysis |
title_sort |
correlation between gastrointestinal symptoms and disease severity in patients with covid-19: a systematic review and meta-analysis |
publisher |
BMJ Publishing Group |
series |
BMJ Open Gastroenterology |
issn |
2054-4774 |
publishDate |
2020-11-01 |
description |
Objective To study the correlation between gastrointestinal (GI) symptoms and disease severity in patients with COVID-19.Design We searched six databases including three Chinese and three English databases for all the published articles on COVID-19. Studies were screened according to inclusion and exclusion criteria. The relevant data were extracted and all the statistical analyses were performed using Revman5.3.Result In a meta-analysis of 9 studies, comprising 3022 patients, 479 patients (13.7%, 95% CI 0.125 to 0.149) had severe disease and 624 patients (14.7%, 95% CI 0.136 to 0.159) had GI symptoms. Of 624 patients with GI symptoms, 118 patients had severe disease (20.5%, 95% CI 0.133 to 0.276) and of 2397 cases without GI symptoms, 361 patients had severe disease (18.2%, 95% CI 0.129 to 0.235). Comparing disease severity of patients with and without GI symptoms, the results indicated: I²=62%, OR=1.21, 95% CI 0.94 to 1.56, p=0.13; there was no statistically significant difference between the two groups. The funnel plot was symmetrical with no publication bias.Conclusion Current results are not sufficient to demonstrate a significant correlation between GI symptoms and disease severity in patients with COVID-19. |
url |
https://bmjopengastro.bmj.com/content/7/1/e000437.full |
work_keys_str_mv |
AT taoyang correlationbetweengastrointestinalsymptomsanddiseaseseverityinpatientswithcovid19asystematicreviewandmetaanalysis AT pingyao correlationbetweengastrointestinalsymptomsanddiseaseseverityinpatientswithcovid19asystematicreviewandmetaanalysis AT mincui correlationbetweengastrointestinalsymptomsanddiseaseseverityinpatientswithcovid19asystematicreviewandmetaanalysis |
_version_ |
1724328403570524160 |